Alignment Healthcare (ALHC) Stock: Buy, Sell, or Hold?
ALHC - Alignment Healthcare, Inc. Common Stock
$7.74
-0.42 (-5.15%)
▼
5d:
+0.91%
30d:
-43.05%
90d:
-67.48%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 29, 2026
26d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 29, 2026 at $7.91 · last confirmed Oct 1, 2026
Strength: 9.4/10
Get Alerted When ALHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ALHC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ALHC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.63
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.75
66.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALHC is currently trading at $7.74, which is considered oversold relative to its 30-day fair value range of $8.44 to $13.60. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.3) compared to its historical average (31.4). Remarkably, the market is currently pricing in an annual earnings decline of 31.0% over the next few years. This pessimistic expectation contrasts with the company's recent 142.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ALHC is in a strong downtrend. Immediate support is located at $7.37, while resistance sits at $8.78. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $22.23 (+187.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALHC is in a strong downtrend. Immediate support is located at $7.37, while resistance sits at $8.78. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $22.23 (+187.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$8.44 -
$13.60
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding ALHC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.1%)
- BULLISH: Trading 187.2% below Wall St target ($22.23)
- WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.44 -
$13.60
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$7.37
Resistance Level
$8.78
Current Trend
Strong Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.29
Wall Street Target
$22.23
(+187.2%)
Revenue Growth (YoY)
31.6%
Earnings Growth (YoY)
142.9%
Profit Margin
0.9%
Valuation Discount vs History
-31.0% cheaper
PE vs Historical
10.3 vs 31.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-31.0%
(market-implied from PE analysis)
1-Year Target
$6.97
(-10%)
2-Year Target
$6.27
(-19%)
3-Year Target
$5.64
(-27%)
3-Yr Target (if PE normalizes)
(PE: 10→31)
$17.23
(+123%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 52.0%)
$51.81
(+569%)
Base:
(SPY PE: 10.3, Growth: 52.0%)
$26.12
(+238%)
Bear:
(PE: 8.7, Growth: 52.0%)
$22.20
(+187%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 42.95 | Current EPS (TTM): $0.19
Bull Case
$17.95
(+132%)
Analyst growth 100.0%, PE expands to 47.2
Base Case
$16.32
(+111%)
Market implied 100.0%, PE stable at 43.0
Bear Case
$5.55
(-28%)
Severe decline -20.0%, PE contracts to 36.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.3 to 31.4
Stabilization Target:
$23.63
(+205.3%)
PE Expansion Potential:
+205.3%
Share & Embed Analysis
Last updated: October 01, 2026 11:06 PM ET
Data refreshes hourly during market hours. Next update: 12:06 AM
Data refreshes hourly during market hours. Next update: 12:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Dawn Christine Maroney
SELL
30000 shares
2026-04-15
John E Kao
SELL
82299 shares
2026-04-13
John E Kao
SELL
215701 shares
2026-04-10
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 49 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$482 | 50 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$342 | 51 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$451 | 44 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$424 | 60 HOLD |
Advanced ALHC Option Strategies
Professional options setups generated by AI based on today's ALHC price and gamma walls.
